Amanta Healthcare’s IPO opens for subscription from September 1-3, 2025, offering investors a promising opportunity to participate in a fast-growing pharmaceutical company specializing in sterile liquid products. Applying through JM Financial ensures a reliable and guided IPO application process, supported by experienced professionals and accessible digital tools.
Amanta Healthcare IPO Overview
Amanta Healthcare Limited, established in 1994, is recognized for its development and manufacture of sterile liquid solutions, including parenteral products (IV fluids, diluents, ophthalmic and respiratory care solutions) produced with cutting-edge ABFS and ISBM technologies. Its upcoming IPO, valued at approximately ₹126 crore, aims to fund capital expenditures for a new manufacturing unit, further strengthening its innovation in the pharma sector.
IPO Details
- Issue Size: ₹126 crore (fresh issue; 1 crore equity shares).
- Price Band: ₹120 to ₹126 per equity share.
- Lot Size: 119 shares (amounting to ₹14,994 at the upper band).
- Lead Manager: Beeline Capital Advisors Pvt Ltd; Registrar: MUFG Intime India Pvt Ltd.
IPO Timeline (Tentative Schedule)
Amanta Healthcare IPO opens on September 1, 2025, and closes on September 3, 2025.
|
IPO Open Date |
Mon, Sep 1, 2025 |
|
IPO Close Date |
Wed, Sep 3, 2025 |
|
Tentative Allotment |
Thu, Sep 4, 2025 |
|
Initiation of Refunds |
Mon, Sep 8, 2025 |
|
Credit of Shares to Demat |
Mon, Sep 8, 2025 |
|
Tentative Listing Date |
Tue, Sep 9, 2025 |
|
Cut-off time for UPI mandate confirmation |
5 PM on September 3, 2025 |
Company Financials
Amanta Healthcare Ltd.'s revenue decreased by 2% and profit after tax (PAT) rose by 189% between the financial year ending with March 31, 2025 and March 31, 2024.
|
Period Ended |
31 Mar 2025 |
31 Mar 2024 |
31 Mar 2023 |
|
Assets |
381.76 |
352.12 |
374.06 |
|
Total Income |
276.09 |
281.61 |
262.70 |
|
Profit After Tax |
10.50 |
3.63 |
-2.11 |
|
61.05 |
58.76 |
56.31 |
|
|
Net Worth |
96.39 |
66.29 |
62.88 |
|
Reserves and Surplus |
67.56 |
39.46 |
36.05 |
|
Total Borrowing |
195.00 |
205.23 |
215.66 |
|
Amount in ₹ Crore |
|||
Objects of the Issue (Amanta Healthcare IPO Objectives)
The Company Amanta Healthcare IPO proposes to utilise the Net Proceeds from the Issue towards the following objects:
|
S.No. |
Objects of the Issue |
Expected Amount (₹ in crores) |
|
1 |
Funding capital expenditure requirements for civil construction work and towards purchase of equipment, plant and machinery for setting up new manufacturing line of SteriPort at Hariyala, Kheda, Gujarat |
70.00 |
|
2 |
Funding capital expenditure requirements towards civil construction work, purchase of equipment, plant and machinery for setting up new manufacturing line for SVP at Hariyala, Kheda, Gujarat |
30.13 |
|
3 |
General corporate purposes |
Key Performance Indicator (KPI)
The market capitalization of Amanta Healthcare IPO is ₹489.25 Cr.
KPI as of Mon, Mar 31, 2025.
|
KPI |
Values |
|
ROE |
12.42% |
|
ROCE |
13.72% |
|
Debt/Equity |
2.02 |
|
RoNW |
10.89% |
|
PAT Margin |
3.86% |
|
EBITDA Margin |
22.11% |
|
Price to Book Value |
3.77 |
Applying for Amanta Healthcare IPO via JM Financial Services
JM Financial Services provides a seamless IPO application service for investors, combining expert guidance with digital ease.
- How to Apply: Investors can use the ASBA process via net banking, or UPI through JM Financial’s platform. JM Financial offers comprehensive prospectus review, up-to-date IPO lists, and dedicated support for new investors.
- Benefits: Get access to professional research, transparent documentation, and reliable application tracking throughout the IPO journey.
FAQs :
• Q1: What is the Amanta Healthcare IPO price band and lot size?
The price band is ₹120–₹126 per share. The minimum application is for one lot of 119 shares.
• Q2: How can investors apply for the IPO?
Investors can apply via ASBA-enabled banks, or digitally through reputed brokers and financial platforms such as JM Financial.
• Q3: What are the key dates for the IPO?
Subscription opens on September 1, 2025, and closes on September 3, 2025. Allotment is expected on September 4, 2025, and listing on September 9, 2025.
• Q4: Who should consider investing?
Investors looking to participate in India’s pharmaceutical sector, seeking a growth-oriented company with a strong manufacturing footprint, may consider applying after their own due diligence.
• Q5: Who are the merchant banker and registrar?
The merchant banker is Beeline Capital Advisors Private Limited, and the registrar is MUFG Intime India Pvt Ltd.
- PAN Card
- Cancelled Cheque
- Latest 6 month Bank Statement (Only for Derivatives Trading)